Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection-Reference-Cited by-同舟云学术

Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection

Published:2019-08 Issue:9 Volume:17 Page:1850-1859.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ahn Sang Hoon,Kim Won^ORCID,Jung Young Kul,Yang Jin Mo,Jang Jae Young,Kweon Yong Oh,Cho Yong Kyun,Kim Yoon Jun,Hong Gun Young,Kim Dong Joon,Um Soon Ho,Sohn Joo Hyun,Lee Jin Woo,Park Sung Jae,Lee Byung Seok,Kim Ju Hyun,Kim Hong Soo,Yoon Seung Kew,Kim Moon Young,Yim Hyung Joon,Lee Kwan Sik,Lim Young Suk,Lee Wan Sik,Park Neung Hwa,Jin So Young,Kim Kyun-Hwan,Choi Won,Han Kwang-Hyub

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

3. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

4. Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy;Papatheodoridis;J Hepatol,2015

5. Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory-wide ecological study;Seto;Aliment Pharmacol Ther,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis;The Korean Journal of Internal Medicine;2024-07-01

2. Anti-SARS-CoV-2 activity of steroids from traditional Chinese medicines in vitro;2024-06-13

3. Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B;Gut and Liver;2024-01-12

4. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B;Journal of Viral Hepatitis;2024-01

5. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target;Viruses;2023-09-12